|Bid||48.92 x 100|
|Ask||48.94 x 700|
|Day's Range||48.77 - 49.01|
|52 Week Range||38.05 - 50.22|
|PE Ratio (TTM)||21.53|
|Forward Dividend & Yield||0.51 (1.07%)|
|1y Target Est||51.50|
Tesla, Marriott, Alibaba, NxStage Medical, Fresenius Medical Care, United Technologies, Rockwell Collins and BlackBerry are among the stocks to watch.
Fresenius Medical (FMS) is banking on its Growth Strategy 2020 plan for gaining market traction in the future. However, lackluster performance in the bourse is a concern.
The National Kidney Foundation announces Peter E. Gladitsch, chief financial officer; Karen Gledhill, senior vice president and general counsel; and Brian Silva, senior vice president of human resources and administration, Fresenius Medical Care North America , will serve as this year's Corporate Chair Team for the Boston Kidney Walk to be held Sunday, Oct.
The National Kidney Foundation announces that Lisa Estrada, senior vice president and chief compliance officer for Fresenius Medical Care North America , has joined the Leadership Committee for the New York City Kidney Walk to be held Sunday, Nov.
To recognize nephrology nurses’ passion and dedication to caring for patients with kidney disease, Fresenius Medical Care North America today announced it is providing the American Nephrology Nurses Association a $20,000 grant for educational scholarships.
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, expanded its regional manufacturing plant in Bandar Enstek, Malaysia. Dato' Seri Dr. Chen ...
Nephrology nurse Katrina Tamayo Guzman, RN, shares many interests with her mom, Delia, RN, BSN, a clinical manager at Fresenius Kidney Care in Elmhurst, Ill. Most striking is their dedication to caring for people living with kidney disease who require dialysis to stay alive.
In addition to selling dialysis products, Fresenius Medical Care also offers dialysis treatment and associated laboratory services to patients through its network of 3,690 clinics.
In 1H17, Fresenius Medical Care (FMS) earned ~1.6 billion euros from the sale of dialysis products, which equals year-over-year growth of 8% on a reported basis.
In 2Q17, Fresenius Medical Care (FMS) reported revenues close to 3.3 billion euros, which represents year-over-year growth of ~11%.
For fiscal 2017, Wall Street analysts have projected Fresenius Medical Care’s net profit margins to be close to 6.2%, which is a YoY decline of ~70 basis points.
For fiscal 2017, Wall Street analysts have projected Fresenius Medical Care’s revenues to be close to $20.8 billion, which equals YoY growth of ~16.0%.
In 1H17, Fresenius Medical Care (FMS) reported revenues close to 9.0 billion euros, which represents 14% YoY growth. At the end of 2Q17, the company operated 3,690 dialysis clinics around the world.
LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Fresenius Medical Care AG & Co. KGAA (NYSE: FMS ), following which ...
Fresenius’s minority-owned kidney dialysis business agreed to acquire NxStage Medical Inc. for about $2 billion.
Categories: Yahoo FinanceGet free summary analysis Fresenius Medical Care AG & Co. KGaA reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Fresenius Medical Care AG & Co. KGaA – DaVita Inc., Baxter International Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Amgen Inc., Sanofi ... Read more (Read more...)
German dialysis provider Fresenius Medical Care (FMS) announced that it will acquire U.S. home dialysis device maker NxStage Medical, Inc. (NXTM) for $2 billion.
Tesla, Marriott, Alibaba, NxStage Medical, Fresenius Medical Care, United Technologies and Rockwell Collins are among the stocks to watch.